Genitourinary Cancer Archives | VJOncology

The GU Cancer Channel on VJOncology is supported by Exelixis. The GU Cancer Channel is also supported by an educational grant from Pfizer Inc. and Merck KGaA. These supporters have no influence over the production of the content.

View overview page

The role of PSMA PET in recurrent prostate cancer

Ravi Madan • 3 Mar 2023

How real-time molecular imaging can improve the management of prostate cancer

Anthony Victor D'Amico • 16 Feb 2023

Key trials in kidney cancer at ASCO GU 2023

Tian Zhang • 17 Feb 2023

Hot topics in RCC at ASCO GU 2023

Matthew R. Zibelman • 16 Feb 2023

Identifying optimal candidates for active surveillance in prostate cancer

Anthony Victor D'Amico • 16 Feb 2023

Advances in PSMA-targeted therapy for prostate cancer

David M. Nanus • 16 Feb 2023

Unanswered questions for the use of PSMA PET in the staging of prostate cancer

David M. Nanus • 16 Feb 2023

Guidelines for using PSMA PET in the staging of prostate cancer

David M. Nanus • 16 Feb 2023

Phase III trial of the impact of PSMA PET/CT in salvage radiotherapy management

Wesley Armstrong • 28 Oct 2022

Use of salvage radiation therapy for biochemical recurrence of prostate cancer after prostatectomy

Alan Dal Pra • 27 Oct 2022

APCCC 2022: PSMA-PET, adjuvant radiotherapy vs early salvage radiotherapy

Silke Gillessen • 18 Oct 2022

BladderPath: reducing bladder treatment times with MRI scans

Nicholas James • 9 Sep 2022

Improving the diagnosis of bladder cancer in the BladderPath study

Nicholas James • 9 Sep 2022

Benefits of upfront staging with PSMA-PET in high-risk prostate cancer

Tobias Maurer • 4 Jul 2022

Salvage treatment options for PSMA-avid lesions

Tobias Maurer • 4 Jul 2022

Future developments in the field of radionuclides

Ken Herrmann • 10 May 2022

1
2
3
4
Next